Review
Version 1
This version is not peer-reviewed
Basic-Clinical Analysis of Parathyroid Cancer
Version 1
: Received: 5 August 2024 / Approved: 6 August 2024 / Online: 6 August 2024 (10:25:55 CEST)
How to cite: Fuenzalida, L.; Indo, S.; Contreras, H.; Rappoport, D.; Cabané, P. Basic-Clinical Analysis of Parathyroid Cancer. Preprints 2024, 2024080415. https://doi.org/10.20944/preprints202408.0415.v1 Fuenzalida, L.; Indo, S.; Contreras, H.; Rappoport, D.; Cabané, P. Basic-Clinical Analysis of Parathyroid Cancer. Preprints 2024, 2024080415. https://doi.org/10.20944/preprints202408.0415.v1
Abstract
Parathyroid cancer (PC) presents clinically as a case of hyperparathyroidism associated with local compression symptoms. The definitive diagnosis of PC is complex as it requires unequivocal criteria of invasion in postoperative biopsy. Given the difficulty in confirming the diagnosis of PC, attempts have been made to address this problem through the search for biomarkers, mainly using immunohistochemistry. Within this theme, the phenomenon of epithelial-mesenchymal transition and cancer stem cells markers have been scarcely studied; and could eventually help discriminate between a diagnosis of parathyroid adenoma or carcinoma. This review presents a clinical approach to the disease; as well as providing a state of the art analysis of basic biomarkers in diagnosis and future projections in this field.
Keywords
parathyroid cancer; primary hyperparathyroidism; biomarkers; epithelial-mesenchymal transition (EMT)
Subject
Biology and Life Sciences, Other
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment